Prothena Corporation plc

Direct answer

Prothena Corporation plc is publicly traded on NASDAQ under the ticker PRTA.

Established in 2012 and headquartered in Dublin, Ireland, Prothena Corporation plc functions as a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapeutic solutions for critical, life-threatening conditions, primarily within the United States. The company's pipeline features several key programs: Birtamimab, an investigational humanized antibody, is currently undergoing...

Can you invest in Prothena Corporation plc?

Yes. Prothena Corporation plc is publicly traded on NASDAQ under the ticker PRTA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Prothena Corporation plc

Detailed equity research is provided by MarketSnap.